RALPH TAGUBA: Open Payments
NPI 1881164739 · KLAMATH FALLS, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$963 in 47 payments from 17 companies in 2025. Trend: 2023 $321 · 2024 $1,029 · 2025 $963
Food & beverage: $947Education: $16
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $185 |
| ABBVIE INC. | 8 | $143 |
| GlaxoSmithKline, LLC. | 5 | $99 |
| Lilly USA, LLC | 4 | $86 |
| Novo Nordisk Inc | 3 | $55 |
| ViiV Healthcare Company | 2 | $53 |
| Boston Scientific Corporation | 2 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Edwards Lifesciences Corporation | 1 | $32 |
Products named: JARDIANCE, PREVNAR 20, MAVYRET, NURTEC ODT, APRETUDE, QULIPTA, BEXSERO, ELIQUIS.
Industry payments across OR — which companies pay providers there.
